Incyte (NASDAQ:INCY) Lowered to “Market Perform” Rating by William Blair

Incyte (NASDAQ:INCY – Get Free Report) was downgraded by equities research analysts at William Blair from an “outperform” rating to a “market perform” rating in a report issued on Tuesday, MarketBeat.com reports. William Blair also issued estimates for Incyte’s FY2025 earnings at $4.21 EPS. Several other equities research analysts also recently commented on the stock. […]

Leave a Reply

Your email address will not be published.

Previous post Sana Biotechnology (NASDAQ:SANA) Stock Rating Upgraded by Citizens Jmp
Next post Spectral AI’s (MDAI) Buy Rating Reaffirmed at HC Wainwright